Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human Abcd2 Antibodies:
anti-Mouse (Murine) Abcd2 Antibodies:
anti-Rat (Rattus) Abcd2 Antibodies:
Go to our pre-filtered search.
ABCD1 (show ABCD1 Antibodies) and ABCD2 are involved in the transport of long and very long chain fatty acids (VLCFA) or their CoA-derivatives into peroxisomes with different substrate specificities, while ABCD3 (show ABCD3 Antibodies) is involved in the transport of branched chain acyl-CoA (show GNPAT Antibodies) into peroxisomes.ABCD4 is deduced to take part in the transport of vitamin B12 (show NDUFB3 Antibodies) from lysosomes into the cytosol.
13-cis (show CISH Antibodies)-retinoic acid induces ABCD2 expression in human monocytes/macrophages.
ABCD2 has a role, but not a strong one, in risk of early recurrent events after transient ischemic attack
results show that although patients with ABCD2 score greater than 4 were more likely to develop recurrent TIA/CVA in short term, those with lesser score still harbour a considerable risk for TIA/CVA
The transcriptional activity of the ABCD2 promoter was strongly increased by ectopic expression of beta-catenin (show CTNNB1 Antibodies) and TCF-4 (show TCF4 Antibodies).
LXRalpha (show NR1H3 Antibodies) is a negative modulator of Abcd2, acting through a novel regulatory mechanism involving overlapping SREBP and LXRalpha (show NR1H3 Antibodies) binding sites
Testosterone metabolites increased expression of ABCD2 mRNA in fibroblasts from X-linked adrenoleukodystrophy patients.
These findings are of particular importance for the attempt of pharmacological induction of ABCD2 as a possible therapeutic approach in X-linked adrenoleukodystrophy.
LDRP (ABCD2) interacts with both farnesylated wild-type and farnesylation-deficient mutant PEX19 (show PEX19 Antibodies). This interaction is mediated by amino acids 1-218 of ALDRP.
ALDRP interacts with PMP70 (show ABCD3 Antibodies). This interaction occurs via the ALDRP C-terminus [374-740] and the PMP70 (show ABCD3 Antibodies) C-terminus [338-659]. This interaction was demonstrated using human PMP70 (show ABCD3 Antibodies) and mouse ALDRP.
ABCD1 (show ABCD1 Antibodies) and its homolog ABCD2 exist mainly as homotetramers in the peroxisomal membrane
Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1 (show ABCD1 Antibodies)-deficient mice
The absence of ABCD2 altered expression of gene clusters associated with lipid metabolism, including PPARalpha (show PPARA Antibodies) signaling.
ABCD2 is a sterol regulatory element binding protein (show CNBP Antibodies) target gene that is highly abundant in fat and opposes the accumulation of dietary lipids generally absent from the triglyceride storage pool within adipose tissue.
Evidence against the adrenoleukodystrophy-related gene acting as a modifier of X-adrenoleukodystrophy.
Abcd1 (show ABCD1 Antibodies) and Abcd2 gene silencing sensitizes astrocytes for inflammation and may have a role in X-adrenoleukodystrophy
ABCD2 plays a role in th degradation of long-chain saturated and omega9-monounsaturated fatty acids and in the synthesis of docosahexanoic acid.
The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ALD subfamily, which is involved in peroxisomal import of fatty acids and/or fatty acyl-CoAs in the organelle. All known peroxisomal ABC transporters are half transporters which require a partner half transporter molecule to form a functional homodimeric or heterodimeric transporter. The function of this peroxisomal membrane protein is unknown\; however this protein is speculated to function as a dimerization partner of ABCD1 and/or other peroxisomal ABC transporters. Mutations in this gene have been observed in patients with adrenoleukodystrophy, a severe demyelinating disease. This gene has been identified as a candidate for a modifier gene, accounting for the extreme variation among adrenoleukodystrophy phenotypes. This gene is also a candidate for a complement group of Zellweger syndrome, a genetically heterogeneous disorder of peroxisomal biogenesis.
ATP-binding cassette, sub-family D, member 2
, ATP-binding cassette, sub-family D (ALD), member 2
, ATP-binding cassette sub-family D member 2
, ATP-binding cassette sub-family D member 2-like
, adrenoleukodystrophy-like 1
, adrenoleukodystrophy-related protein
, adrenoleukodystrophy related